Gerald Phd Mcmahon - Net Worth and Insider Trading

Gerald Phd Mcmahon Net Worth

The estimated net worth of Gerald Phd Mcmahon is at least $6,903 dollars as of 2024-04-29. Gerald Phd Mcmahon is the President and CEO of Harpoon Therapeutics Inc and owns about 300 shares of Harpoon Therapeutics Inc (HARP) stock worth over $6,903. Details can be seen in Gerald Phd Mcmahon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gerald Phd Mcmahon has not made any transactions after 2019-05-14 and currently still holds the listed stock(s).

Transaction Summary of Gerald Phd Mcmahon

To

Gerald Phd Mcmahon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerald Phd Mcmahon owns 4 companies in total, including Harpoon Therapeutics Inc (HARP) , Celldex Therapeutics Inc (CLDX) , and Oncotelic Therapeutics Inc (OTLC) among others .

Click here to see the complete history of Gerald Phd Mcmahon’s form 4 insider trades.

Insider Ownership Summary of Gerald Phd Mcmahon

Ticker Comapny Transaction Date Type of Owner
HARP Harpoon Therapeutics Inc 2019-05-14 director & President and CEO
CLDX Celldex Therapeutics Inc 2016-12-14 director
OTLC Oncotelic Therapeutics Inc 2011-09-02 director
PARD Poniard Pharmaceuticals Inc 2011-06-09 director

Gerald Phd Mcmahon Latest Holdings Summary

Gerald Phd Mcmahon currently owns a total of 1 stock. Gerald Phd Mcmahon owns 300 shares of Harpoon Therapeutics Inc (HARP) as of May 14, 2019, with a value of $6,903.

Latest Holdings of Gerald Phd Mcmahon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HARP Harpoon Therapeutics Inc 2019-05-14 300 23.01 6,903

Holding Weightings of Gerald Phd Mcmahon


Gerald Phd Mcmahon Form 4 Trading Tracker

According to the SEC Form 4 filings, Gerald Phd Mcmahon has made a total of 3 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Harpoon Therapeutics Inc is the acquisition of 100 shares on May 14, 2019, which cost Gerald Phd Mcmahon around $10,160.

Insider Trading History of Gerald Phd Mcmahon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gerald Phd Mcmahon Trading Performance

GuruFocus tracks the stock performance after each of Gerald Phd Mcmahon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald Phd Mcmahon is 20.94%. GuruFocus also compares Gerald Phd Mcmahon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald Phd Mcmahon within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gerald Phd Mcmahon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gerald Phd Mcmahon

Average Return

28.29%

Average return per transaction

Outperforming Transactions

100%

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.51 20.94 27.94 28.29 43.93 -40.96
Relative Return to S&P 500(%) 13.24 20.34 21.01 28.8 23.31 -53.44

Gerald Phd Mcmahon Ownership Network

Ownership Network List of Gerald Phd Mcmahon

No Data

Ownership Network Relation of Gerald Phd Mcmahon


Gerald Phd Mcmahon Owned Company Details

What does Harpoon Therapeutics Inc do?

Who are the key executives at Harpoon Therapeutics Inc?

Gerald Phd Mcmahon is the director & President and CEO of Harpoon Therapeutics Inc. Other key executives at Harpoon Therapeutics Inc include 10 percent owner Vijay K Lathi , Chief Medical Officer Luke Nathaniel Walker , and Principal Fin. & Acctng Ofc. Frank J Lanza .

Harpoon Therapeutics Inc (HARP) Insider Trades Summary

Over the past 18 months, Gerald Phd Mcmahon made no insider transaction in Harpoon Therapeutics Inc (HARP). Other recent insider transactions involving Harpoon Therapeutics Inc (HARP) include a net purchase of 21,397,205 shares made by Merck & Co., Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Harpoon Therapeutics Inc (HARP) in total and bought 21,397,205 shares, with a net purchase of 21,397,205 shares. During the past 18 months, 0 shares of Harpoon Therapeutics Inc (HARP) were sold and 21,397,205 shares were bought by its insiders, resulting in a net purchase of 21,397,205 shares.

Harpoon Therapeutics Inc (HARP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Harpoon Therapeutics Inc Insider Transactions

No Available Data

Gerald Phd Mcmahon Mailing Address

Above is the net worth, insider trading, and ownership report for Gerald Phd Mcmahon. You might contact Gerald Phd Mcmahon via mailing address: 300 Elliott Avenue West, Suite 500, Seattle Wa 98119-4114.

Discussions on Gerald Phd Mcmahon

No discussions yet.